Adapting to FDA’s 2023 Cybersecurity Guidelines: Cloud and Device Strategies
Discover an informative webinar decoding The Food and Drug Administration’s (FDA) 2023 guidelines about the cloud and medical device cybersecurity landscape. Medical device cybersecurity has undergone a game-changing transformation with The FDA’s updated 2023 guidelines, seamlessly integrating both medical device and cloud computing aspects. In this webinar, specifically designed for research and development (R&D), cyber and development, security and operations (DevSecOps) professionals building and maintaining medical devices, BioT, Sternum and Arnall Golden Gregory will unravel these pivotal updates. The expert panel will dissect the intricacies of the new guidelines, focusing on the dual importance of device security and cloud-based data management. The webinar will explore key areas such as threat modeling for interconnected devices, cybersecurity risk assessment in cloud environments, interoperability considerations, management of third-party software components and the development of comprehensive Software Bills of Materials (SBOM). Key discussions will include safeguarding patient data in the cloud, ensuring secure data transmission between devices and cloud platforms, and navigating the broader evolving regulatory framework for cloud-enabled medical devices. Join this insightful webinar to be part of a forward-thinking community eager to master the future of medical device cybersecurity in the cloud era.
